DEXTROSE ORAL GEL
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The Defense Logistics Agency awarded DMS PHARMACEUTICAL GROUP INC a contract valued at $20.14 on July 30, 2026, under solicitation SPE2DP26F8432, which is a delivery order tied to the broader contract SPE2DX25D9900. The sole line item consists of DEXTROSE ORAL GEL identified by NSN 6505014253168 and PR 7017690513, indicating the procurement is for a specific pharmaceutical product likely intended for medical or emergency use within the Department of Defense. The contract is classified as a federal award with no set-aside designation and no assigned NAICS code, reflecting its straightforward nature and narrow scope. Despite the minimal monetary value, the contract is formally documented and linked to DIBBS, with performance and administrative details managed under the DLA’s framework, and the point of contact information is not provided in the public data.
General Info
Agency
Contract Value
$20.14NAICS
Place of Performance
Not specifiedSet-Aside
Awardee
Award Issued Date
Documents
(2)AI Contract Breakdown
Uniform Contract FormatWhat is UCF?
Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
